NCIt definition : A preparation of autologous cytotoxic T-lymphocytes (CTLs) that are specifically reactive
to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP-2A) and expressing the
co-stimulatory domain 4-1BB (CD137), with potential antineoplastic activity. Upon
administration of the EBV/LMP-2A-specific autologous CD8 T-cells to patients with
EBV-positive tumors, these cells bind to and cause cell death in EBV-infected cells.
This inhibits proliferation of EBV LMP-2A-expressing tumor cells. EBV LMP-2A is expressed
in various malignancies and plays a key role in tumor cell proliferation and survival.
4-1BB, an inducible costimulatory member of the tumor-necrosis factor receptor (TNFR)
family, is expressed on activated T-cells. It activates additional CD8 T-cells, prevents
activation-induced cell death of CD8 T-cells, and selectively induces T-helper 1
(Th1)-type cytokines such as interferon (IFN)-gamma and tumor-necrosis factor-alpha
(TNF-alpha).;